title: Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
authors.forename: Dimitrios P
authors.initials: DP
authors.lastname: Bogdanos
authors.forename: Christos
authors.initials: C
authors.lastname: Liaskos
authors.forename: Albert
authors.initials: A
authors.lastname: Pares
authors.forename: Gary
authors.initials: G
authors.lastname: Norman
authors.forename: Eirini I
authors.initials: EI
authors.lastname: Rigopoulou
authors.forename: Llorenç
authors.initials: L
authors.lastname: Caballeria
authors.forename: George N
authors.initials: GN
authors.lastname: Dalekos
authors.forename: Juan
authors.initials: J
authors.lastname: Rodes
authors.forename: Diego
authors.initials: D
authors.lastname: Vergani
mesh_terms: D000974:Antibodies, Antinuclear / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000276:immunology* / Q000503:physiopathology; D028861:Nuclear Pore Complex Proteins / Q000276:immunology*; D012720:Severity of Illness Index
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers; C063865:NUP210 protein, human; D028861:Nuclear Pore Complex Proteins